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Abstract 27 
Introduction: 28 
Arthroscopic capsular release for adhesive capsulitis of the shoulder is a treatment 29 
option. The present study aimed to investigate the clinical outcomes following 30 
arthroscopic capsular release among idiopathic, diabetic and secondary adhesive 31 
capsulitis. 32 
Hypothesis: 33 
Different aetiological groups yield variable outcomes following arthroscopic capsular 34 
release. 35 
Materials and Methods: 36 
A literature search was performed using MEDLINE, EMBASE, CINAHL and the 37 
Cochrane Database in April 2017. Comparative studies that reported range of motion 38 
or functional outcomes following arthroscopic capsular release in patients with 39 
adhesive capsulitis were included. A systematic review of the studies was conducted 40 
following the PRISMA guidelines. 41 
Results: 42 
Six studies met the eligibility criteria. The overall population included 463 patients; 43 
203 idiopathic, 61 diabetic and 199 secondary cases. Of four studies comparing 44 
idiopathic and diabetic patients, three reported significantly worse range of movement 45 
and function in the diabetic group at various follow up points. No significant difference 46 
in function and motion was reported between the idiopathic and secondary groups. 47 
Recurrent pain was highest in diabetic patients (26%) compared to idiopathic groups 48 
(0%) and the secondary group had a higher rate of revision surgery when compared to 49 
the idiopathic group (8.1% vs. 2.4%) 50 
Discussion: 51 
Arthroscopic capsular release has a high success rate regardless of the underlying 52 
aetiology. However, diabetic patients are reported to have more residual pain, reduced 53 
motion and inferior function compared to idiopathic cases. The rate of revision capsular 54 
release is higher among patients with post-surgical adhesive capsulitis when compared 55 
to idiopathic cases. 56 
Level of evidence: Level IV, systematic review. 57 
Keywords Shoulder; Frozen shoulder; Adhesive capsulitis; Capsular release; 58 
Arthroscopy; Diabetes mellitus 59 
 60 
Running title: A systematic review of aetiology and outcomes in shoulder adhesive capsulitis 
   
 
 3 
 61 
1. Introduction 62 
Adhesive capsulitis of the shoulder is common with an estimated incidence between 2 63 
and 5% in the normal population [1, 2]. Diabetic patients have a two to four times 64 
greater risk of developing frozen shoulder compared to the general population, with 65 
an estimated lifetime risk of 10-20%. [3, 4-6]. The condition was previously defined 66 
by Lundberg as restricted movement isolated to the glenohumeral joint with less than 67 
135° of shoulder elevation and no other clinical or radiological explanation for this 68 
reduced motion [3]. The condition is more common among females and has a peak 69 
incidence between 40 and 60 years [7-9]. Lundberg classified adhesive capsulitis into 70 
primary frozen shoulder, subdivided into diabetic patients and those with no other 71 
explanation, and secondary frozen shoulder, again subdivided into post-traumatic and 72 
iatrogenic [3]. The latter is a heterogeneous group of patients that is associated with 73 
great challenges in terms of both diagnosis and treatment. Ultimately, this group may 74 
require treatment of their underlying primary shoulder condition and their prognosis 75 
can be inferior. However, to our knowledge there are no systematic reviews prior to 76 
ours that have addressed this question.  77 
Most cases of adhesive capsulitis are initially managed non-operatively with Griggs et 78 
al. reporting 90% satisfaction after an exercise programme and only 7% requiring 79 
surgical intervention [10]. However, Shaffer et al. demonstrated that 50% of patients 80 
continued to have mild pain, stiffness and a deficit in shoulder range of motion after 81 
seven years [11]. Failure to see an improvement in pain or function after 3 months of 82 
non-operative treatment should lead to consideration of surgical intervention [12, 13]. 83 
Arthroscopic capsular release allows a controlled and complete release of the contracted 84 
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capsule [14]. Studies have demonstrated significant early improvements in over 80% of 85 
patients within 2 to 6 weeks [15, 16], and these improvements in motion, pain and 86 
function have been maintained in the long-term [17]. In patients with resistant adhesive 87 
capsulitis, who have failed non-operative treatment and manipulation, arthroscopic 88 
capsular release has similarly been shown to improve function, pain relief and range of 89 
motion at intermediate-term follow up [18]. The underlying aetiology of adhesive 90 
capsulitis may alter the effectiveness of treatment. This systematic review therefore 91 
aims to identify whether there are any differences in outcomes between idiopathic, 92 
diabetic or secondary adhesive capsulitis following arthroscopic capsular release. The 93 
present hypothesis is that controversies on the effectiveness of arthroscopic 94 
capsular release stem from variable clinical and functional outcomes among the 95 
different aetiological groups.   96 
2. Material and Methods 97 
A systematic review of the literature was conducted according to the PRISMA 98 
guidelines [19] using the online databases MEDLINE®, Embaseᵀᴹ, CINAHL® and the 99 
Cochrane Central Register of Controlled Trials. A summary of the Medline search is 100 
illustrated in Table 1.  The searches were performed independently by two authors (TB 101 
and RJ) on 1 April 2017 and 19 April 2017 to ensure accuracy. 102 
Eligibility criteria were derived from the hypothesis and the study parameters outlined 103 
here: 104 
I. Participants – Adult patients with adhesive capsulitis considered for surgical 105 
treatment  106 
II. Intervention – Arthroscopic capsular release in primary idiopathic adhesive 107 
capsulitis 108 
III. Comparison – Arthroscopic capsular release in diabetic and secondary 109 
adhesive capsulitis 110 
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IV. Outcomes – Primary outcome measure: shoulder range of motion (ROM). 111 
Secondary outcome measure: clinical outcomes measure scores, health related 112 
questionnaires, complications/revision procedure, and patients satisfaction 113 
All identified studies that compared the outcomes of arthroscopic capsular release in 114 
idiopathic adhesive capsulitis with those undergoing surgery for diabetic or secondary 115 
adhesive capsulitis were included, provided that functional outcome or shoulder range 116 
of movement was reported. Secondary outcome measures of interest included pain 117 
scores and requirement for further surgery. Only primary research published in the 118 
English language was considered for review. References of full texts were also 119 
reviewed to identify other potential relevant studies. The acquisition of articles is 120 
summarised as a flow diagram in Figure 1.  121 
The principal exclusion criteria were: abstract only publications, conference 122 
proceedings, case reports, review articles, previous surgery unrelated to the aetiology 123 
or current treatment of adhesive capsulitis, open capsular release, and comparison with 124 
other treatments. Studies which reported on treatment of concomitant shoulder 125 
conditions only were excluded. Equally, studies, which looked at cadaveric models, 126 
biomechanics or laboratory analyses, only were excluded. 127 
All relevant studies were critically appraised employing narrative data synthesis. This 128 
process was conducted by two independent reviewers (TB and RJ). Where there was 129 
discrepancy, it was resolved by a third independent reviewer (AS). Quality assessment 130 
and risk of bias was evaluated using criteria derived from the validated Methodological 131 
Index for Non-Randomised Studies (MINORS), outlined in Table 2 [20]. Data on 132 
functional outcomes, pain and range of movement were extracted from each study. Full 133 
quantitative data synthesis was not feasible due to the marked heterogeneity of the 134 
results and outcome measures reported by the studies.  135 
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3. Results 138 
The search strategy, outlined in Figure 1, identified six studies eligible for inclusion 139 
from a total of 208 publications spanning the period from 1967 to 2014. All studies 140 
included were comparative case series (level IV) [21-26]; three studies compared 141 
idiopathic to diabetic cases [22, 25, 26], two compared idiopathic to secondary cases 142 
[23, 24], and the final study compared idiopathic to both diabetic and secondary 143 
adhesive capsulitis [21]. The overall population included 463 patients; 203 idiopathic, 144 
61 diabetic and 199 secondary cases. The secondary cases were made up of 69 post-145 
trauma, 100 post-surgical and 30 degenerative conditions. The length of follow-up 146 
varied, with an overall mean of 37.5 months, the shortest at 13 months in Cinar et al 147 
and the longest at 8 years in Nicholson et al [21, 22]. Important details of the included 148 
clinical studies are given in Table 3. The latter depicts further details of studies, which 149 
were associated with marked heterogeneity in relation to patient selection especially in 150 
terms of primary shoulder condition associated with secondary frozen shoulder, as well 151 
as additional surgical intervention. Nicholson et al who reported 24 concomitant 152 
subacromial decompression and Jerosch et al who reported 55 variable additional 153 
surgical procedures [21, 24].  None of the studies used a defined power calculation and 154 
3 of the studies had sample sizes with less than 45 cases.  155 
Range of Motion 156 
Shoulder flexion, external rotation and internal rotation were the most commonly 157 
reported shoulder range of motion (ROM). Table 4 illustrates the recorded values in the 158 
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included studies. All studies demonstrated that arthroscopic capsular release produced 159 
a statistically significant improvement in ROM in all three subgroups of adhesive 160 
capsulitis. Three of the four studies comparing idiopathic and diabetic cases 161 
demonstrated a greater improvement of motion in the idiopathic group [22, 25, 26]. 162 
Two studies demonstrated improved range of motion at only the six month follow up 163 
point [25, 26], whereas Cinar et al. reported improved abduction and internal rotation 164 
until final follow up at a mean of 53 months (p<0.05) [22]. The two studies comparing 165 
idiopathic and secondary cases demonstrated no significant differences in range of 166 
motion between the groups [21, 23]. Three studies, Cinar et al. Mehta et al. and Cho et 167 
al, reported improvement in range of motion among different aetiological groups. 168 
Comparisons of results between different studies demonstrated no significant 169 
differences in these range of motions between the idiopathic and diabetic aetiological 170 
groups. 171 
Patient reported outcome measures (PROMs) 172 
A variety of PROMs were utilised by the reviewed studies and are illustrated in Table 173 
5.  All studies recorded a statistically significant improvement in PROMs in all three 174 
groups from pre-operative to post-operative scores.  175 
The Constant score was recorded in four studies. Two compared idiopathic and diabetic 176 
cases and demonstrated a significantly greater improvement in the idiopathic group [22, 177 
25]. Mehta et al [25] reported better results up until six months (p<0.01) whereas Cinar 178 
et al [22] demonstrated improved results at final follow up (p<0.05). The other two 179 
studies compared idiopathic and secondary cases but reported no significant differences 180 
between the groups [23, 24].  181 
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The American shoulder and elbow score (ASES) was used in two studies; one 182 
comparing idiopathic and diabetic cases that demonstrated greater improvements in the 183 
ASES amongst the idiopathic group at one year (p=0.025) but not at final follow up 184 
[26]. The other compared idiopathic to both diabetic and secondary cases and reported 185 
a trend to improved ASES in the idiopathic group compared to the diabetic group 186 
(p=0.056) [21]. 187 
Pain 188 
Comparison of pain scores was reported in five of the included studies, details are 189 
illustrated in Table 6. The pain visual analogue score (VAS) was reported in three 190 
studies [21, 23, 26] one reported the severity of pain (none, mild, moderate or severe) 191 
[22] and residual pain at follow up in the last study [25].  Nicholson reported pain was 192 
a significant problem in 22% of cases in the first six weeks post-operatively but that 193 
only diabetic patients had a higher incidence of residual pain (p=0.0176) [21]. Cinar et 194 
al. reported 26% of their diabetic patients had residual pain at final follow up (mean 54 195 
months) compared to 0% in the idiopathic group [22]. The remaining three studies 196 
demonstrated no significant differences in pain relief between the groups (mean follow 197 
up 24 to 46 months) [23, 25, 26]. 198 
Revision procedures 199 
Only two studies clearly stated their revision rate. Nicholson reported no revision 200 
procedures were required in any group [21]. Elhassan et al. reported a revision rate of 201 
2.4% in the idiopathic group compared to 8.1% in the secondary group at a mean of 46 202 
months follow up. In comparison, among patients with secondary frozen shoulder the 203 
rate of revision was 10.4% in the post-surgical group, and 3.8 % in the post-traumatic 204 
group [23].  205 
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4. Discussion 209 
The included studies demonstrate that regardless of aetiology, arthroscopic capsular 210 
release provides statistically significant improvements in PROMs, ROM and pain relief 211 
in adhesive capsulitis. Comparison of outcomes between idiopathic and diabetic cases 212 
suggested that greater improvement in ROM and PROMS could be achieved in the 213 
idiopathic group especially early post-operatively (up to six months) but two studies 214 
also reported continued improvement comparatively until later stages of follow up 215 
(mean 36 to 53 months).  216 
The finding of poorer outcomes in diabetics when compared to idiopathic cases has 217 
previously been reported [27-29]. Moren-Hybbinette et al [19] demonstrated that 65% 218 
of diabetic patients with adhesive capsulitis had limitation of range of motion after non-219 
operative treatment at a mean of 29 months [30].  Massoud et al reported that 22% of 220 
diabetics were unsatisfied and 68% still had limitation in motion after surgical 221 
intervention [31]. Studies comparing outcomes in idiopathic and diabetic patients have 222 
demonstrated inferior outcomes in diabetic patients after non-operative treatment [10], 223 
manipulation under anaesthesia [12, 32, 33], and arthroscopic release [34]. Jenkins et 224 
al. retrospectively compared manipulation under anaesthesia in diabetic and non-225 
diabetic patients and showed that diabetics had a higher return to theatre for 226 
unsatisfactory outcomes (36% versus 15%) [33]. Pollock et al demonstrated that 227 
manipulation and arthroscopic release in resistant adhesive capsulitis was more 228 
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successful in idiopathic cases than diabetics with an excellent result seen in only 18% 229 
of diabetics compared to 62% of idiopathic and 83% of post traumatic cases [34]. 230 
The evidence reviewed supports these inferior outcomes in diabetics compared to 231 
idiopathic cases. A possible explanation is that diabetic patients may have more pain 232 
post-operatively and therefore do worse initially as pain can inhibit range of motion and 233 
function. Two included studies demonstrated worse early results in diabetic patients; 234 
Mehta et al [25] reported improved ROM and Constant score at 6 months and Cho et al 235 
[26] improved ROM and ASES at 12 months. These two studies also reported a non-236 
significant increase in pain post-operatively in the diabetic group; Mehta et al. showed 237 
residual pain in 33% of diabetics compared to 9.5% of idiopathic cases [25] and Cho et 238 
al reported a residual mean VAS score of 2.2 in diabetics compared to 1.4 in idiopathic 239 
cases [26] Cinar et al demonstrated worse function and motion in diabetics at final 240 
follow up and similarly demonstrated a higher residual level of pain in diabetics (26% 241 
versus 0%) [22]. 242 
Comparison of idiopathic and secondary cases did not demonstrate any significant 243 
differences in ROM or PROMS in the studies reviewed. Elhassan et al. did report 244 
significantly poorer outcomes in the post-surgical subgroup in terms of forward flexion, 245 
pain and SSV but these findings were not reproduced in other studies [23]. However, 246 
the same authors reported revision rates for residual stiffness to be four times higher in 247 
these secondary cases [23]. The highest revision rate was in the post-surgical group 248 
(10.4%), of which 40% undergoing revision had continued unsatisfactory outcomes. 249 
Interpretation of these figures is difficult as the secondary group was heterogeneous 250 
and included 48 post-surgical and 26 post-trauma cases. Similarly, the post-surgical 251 
group included a variety of procedures including 17 rotator cuff repairs, 12 252 
stabilisations and 5 SLAP repairs. Arthroscopic release in post-surgical and post-253 
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trauma patients has been associated with worse outcomes than idiopathic cases. 254 
Holloway et al. compared outcomes after arthroscopic release in three groups; 255 
idiopathic, post-fracture and post- surgery cases. The authors reported that patients with 256 
post-operative adhesive capsulitis had significantly worse scores for pain (<0.03), 257 
satisfaction (p<0.004) and functional activity (p<0.002) [35]. Wang et al. compared the 258 
results of manipulation under anaesthesia in the same three groups and in contrast 259 
demonstrated that pain, range of motion and functional outcomes were all significantly 260 
worse in the post-traumatic group (p<0.01) [27]. Therefore, although the effectiveness 261 
of interventions for adhesive capsulitis seems to be dependent upon the underlying 262 
aetiology, the precise relationship remains uncertain. 263 
The presence of concomitant stiffness and traumatic injuries complicates management 264 
of adhesive capsulitis, as there is concern that simultaneous treatment may result in 265 
increased stiffness post-operatively. Although controversial, the traditional treatment 266 
of concomitant stiffness and rotator cuff tear is to prioritise the treatment of the stiffness 267 
first and perform a delayed cuff repair in order to avoid the increased risk of post-268 
operative stiffness and disability [36]. There is increasing evidence that simultaneous 269 
repair and arthroscopic release can give comparable range of motion and functional 270 
scores [37-39] as well as a lower re-tear rate 0% versus 20% (p=0.009) [37]. The 271 
response of the post-surgical adhesive capsulitis seems to be less predictable than in the 272 
idiopathic cases [35]. However, grouping post-surgical conditions together may limit 273 
the ability of studies to demonstrate differences in outcome for particular subgroups of 274 
operations. Further work is therefore required to know if specific prior surgical 275 
procedures place the patient at higher risk of recurrent symptoms and require earlier 276 
intervention. In addition, it is important to recognise the emergence of alterative 277 
techniques in the management of adhesive capsulitis. The use of capsular hydro-278 
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dilatation has become a well-established approach in the treatment of this condition. A 279 
detailed review of relevant outcomes following this intervention was beyond the scope 280 
of the present study. Bell et al did however report variability in outcomes among 281 
different aetiological groups [40]. Following capsular hydrodilation all non-diabetic 282 
patients showed considerable improvement, compared to a shorter benefit in diabetic 283 
patients [40]. A recent randomised trial comparing arthroscopic capsular release with 284 
hydro-dilatation demonstrated overall equivalent results [41]. The group treated with 285 
arthroscopic release did however obtain significant superior results with 5 points 286 
difference on the Oxford shoulder score (P=0.023) [41]. In contrast, Yukata et al have 287 
recently reported the successful outcomes of limited minimally invasive ultrasound-288 
guided coracohumeral ligament release [42]. Both studies were not powered to detect 289 
subgroup difference. Hence, larger comparative studies are still required to determine 290 
the long-term outcomes among different aetiological groups.  291 
Evaluation of the reviewed studies against the MINORs criteria [20] demonstrated a 292 
variation in the quality of included studies as illustrated in Table 2. The included studies 293 
all provided level IV evidence. The use of different outcome measures limited the 294 
ability to compare or combine results and the variation in follow up from 13 months to 295 
99 months has the potential to influence results as previous work has demonstrated that 296 
outcomes improve significantly with time [43]. In addition, none of the studies reported 297 
outcomes stratification according to disease stage. Four studies reported complications, 298 
all stated none were observed but provided limited detail of what would be defined as 299 
a complication. Only two of the six studies explicitly stated the requirement for revision 300 
surgery and the lack of this information restricts the conclusions that can be drawn on 301 
this outcome. The availability of only six studies for review limited the number of 302 
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patients included for the systematic review and further studies of high quality are likely 303 
to improve the data available and strengthen the conclusions that can be drawn.  304 
 305 
5. Conclusions 306 
Arthroscopic capsular release produces significant improvement in ROM and PROMs 307 
regardless of aetiology. The present review demonstrated that improvements are similar 308 
across idiopathic, diabetic and secondary shoulder adhesive capsulitis groups. 309 
Nonetheless, diabetic patients are reported to have more residual pain, reduced motion 310 
and function compared to idiopathic cases. The revision rate was also higher among 311 
post-surgical when compared to idiopathic cases of adhesive capsulitis. 312 
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8. Figure Legends: 448 
Figure 1: flow diagram of review process 449 
9. Tables: 450 
Table 1: Illustration of Medline Search Strategy 451 
Number Search term Search results 
1 Adhesive capsulitis 581 
2 Frozen shoulder 686 
3 Diabetes 468,406 
4 Primary 1,191,381 
5 Secondary 555,476 
6 Arthroscopy 22,696 
7 Capsular release or Joint Capsule 292 
8 Lysis  39,701 
9 #1 OR #2 1,154 
10 #3 OR #4 OR #5 2,008,474 
11 #6 OR #7 OR #8 62,424 
12 #9 AND #10 AND #11 66 
 452 
 453 
 454 
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 459 
Table 2: Assessment of methodological quality and risk of bias according to 460 
MINORs criteria 461 
Criteria Nicholson 
2003 
Cinar et 
al 2010  
Elhassan  
et al 2010  
Jerosch et 
al 2013  
Mehta et 
al 2014  
Cho et al    
2016  
Clearly stated aim + + + + + + 
Generalizable results - + - - - - 
Comprehensive inclusion and exclusion of patients + ? + ? + + 
Baseline equivalence of study groups - - + + + + 
Pragmatic approach (used and accepted method of 
treatment) rehab, indications 
- + - + - + 
Study registered and/or protocol published - - + - - - 
Adequate control group or standard treatment group - - - - - - 
Data collection followed a pre-determined protocol - - - - - - 
Outcome measures reflect the aim of the study + - + - + + 
Clearly stated primary outcome measure - - - - - - 
Analyses adjusted to account for multiple outcomes - - - - - - 
No historical comparison between control and study 
groups 
? + + ? ? + 
Blind evaluation of endpoints (Reasons for not blinding 
observers clearly stated) 
- - - - - + 
Follow-up period appropriate for the aim of the study - - + - + + 
All cases accounted for, no significant loss to follow-up + + + - + + 
Level of evidence IV IV IV IV IV IV 
Total (n/15) 3/15 5/15 8/15 3/15 6/15 9/15 
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 466 
Table 3: Summary of the included studies  467 
Study Design Sample Size Intervention (s) Follow up 
Mean  +/- (range) 
Outcome Measures 
Nicholson 
2003 
Comparative 
case series 
68 shoulders 
17 idiopathic 
8 diabetic 
43 secondary 
15 Post-trauma (5 Tuberosity Fracture, 1 
dislocation, 9 other trauma) 
20 Post-surgical (10 cuff repair, 9 
acromioplasties, 1 surgical neck ORIF)  
8 post subacromial impingement 
3 months home 
physiotherapy 
50% corticosteroid injection 
Arthroscopic capsular release 
(360° release) 
Post release MUA 
24 concomitant SAD 
Mean 3 years (2-
8 years) 
ASES 
SST 
VAS pain 
ROM 
Cinar et al 
2010 
Comparative 
case series 
28 shoulders 
13 idiopathic 
15 diabetic 
Mean age 50 years (40 to 65) 
Min 6 months physiotherapy 
Arthroscopic capsular release 
(Selective release) 
Mean 54.1 
months (13-99 
months) 
UCLA score 
Constant score 
ROM 
Elhassan et al 
2010  
Comparative 
case series 
115 patients 
41 idiopathic  
74 secondary 
26 post-trauma (7 fracture, 10 post cuff 
tear, 3 post SLAP tear, 1 dislocation and 5 
others) 
 48 post-surgical (17 cuff repair, 12 
stabilisations, 6 SAD, 5 SLAP repair, 4 
arthroplasty, 4 other)  
Mean age 52 years (36 to 81) 
Min 6 months conservative  
Arthroscopic capsular release 
(360° release) 
 
Mean 46 months 
(24-89 months) 
ROM 
SSV 
VAS pain 
Constant score 
Jerosch et al 
2013  
Comparative 
case series 
173 shoulders 
91 idiopathic 
Min 6 months conservative  
Arthroscopic capsular release 
Median 36 
months (14-67 
months) 
Constant score 
ROM 
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82 secondary; 28 post-trauma, 32 post-
surgical , 22 degenerative disease 
48 years (25 to 80) 
(360° release) 
31 SAD 
10 ACJ resection 
7 calcium deposit excision 
4 implant removal 
3 rotator cuff repair 
VAS pain 
Mehta et al 
2014 
Comparative 
case series  
42 patients 
21 idiopathic 
21 diabetic 
Mean age 54 years (48 to 65) 
Min 6 months conservative  
Arthroscopic capsular release 
(360° release) 
 
2 years Constant score 
ROM 
Cho et al 2016  Comparative 
case series  
37 shoulders 
20 idiopathic  
17 diabetic  
Mean age 55.6 years  
Min 3 months conservative  
Pre release MUA 
Arthroscopic capsular release 
(360° release) 
Intra-articular injection 
24 months ASES 
UCLA score 
VAS pain 
ROM 
SAD: subacromial decompression. ACJ: acromio-clavicular joint 468 
 469 
 470 
 471 
 472 
 473 
 474 
 475 
 476 
 477 
 478 
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 483 
Table 4: Summary of the improvement in range of movement in included studies  484 
Study Idiopathic Diabetic Secondary Statistically significant difference 
Nicholson 
2003   
N = 68 
FF 83 to 170 (87) 
ER 10 to 57 (47) 
IR buttock to T10 
FF 85 to 154 (69)  
ER 12 to 45 (33) 
IR Buttock to T11 
FF 99 to 164 (65) 
ER 15 to 58 (43) 
IR Buttock to T11 
Diabetic group had lower active ER 
compared to all patients (44 vs. 58; p = 
0.004) 
Cinar et al 
2010 
N = 28 
FF 69.2 to 153.1 
Abduction 66.5 to 
153 
ER 3.2 to 72.3 
IR 14.6 to 67.7 
FF 75.3 to 141 
Abduction 56.3 to 
128.3 
ER 11.7 to 56.7 
IR 15.3 to 34.7 
N/A 
N/A 
N/A 
N/A 
Significantly greater improvement in 
abduction and IR in idiopathic group 
(P<0.05) 
Elhassan et al 
2010  
N = 115 
FF 100 to 140 
ER 14 to 35 
IR L5 to T12 
N/A 
N/A 
N/A 
FF 94.7 to 130 
ER 13.1 to 37.6  
IR sacrum to T12 
Post-surgical worse FF than idiopathic cases 
(p=0.02)  
Jerosch et al 
2013  
N = 173 
Abduction 68 to 163 
Adduction 28 to 35 
FF 78 to 173 
ER 11 to 69 
IR 28 to 69 
N/A 
N/A 
N/A 
N/A 
N/A 
Abduction 68 to 
169 
Adduction 29 to 35 
FF 92 to 172 
ER 10 to 69 
IR 39 to 69 
Nil 
Mehta et al 
2014  
N = 42 
FF 80.2 to 173.2 
Abduction 75.5 to 
170.2 
ER 15.6 to 68 
IR 16.7 to 64.2 
FF 78.1 to 165.2 
Abduction 63.9 to 
156 
ER 15.8 to 58 
IR 15.6 to 56.7 
N/A 
N/A 
N/A 
N/A 
Improved ROM at 6 months in idiopathic 
group (p<0.01) 
Cho et al 2016  
N = 37 
FF 95 to 169.5 
ER 15.3 to 65.8 
FF 90 to 168.8 
ER 15 to 65.9 
N/A 
N/A 
At 3 and 6 months FF better in idiopathic 
group (p=0.011 and p=0.045) 
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IR 16.4 to 9 IR 17.2 to 9.8 N/A At 6 months ER better in idiopathic group 
(p=0.021) 
At 6 and 12 months IR better in idiopathic 
group (p=0.006 and p=0.041) 
FF: forward flexion, ER: external rotation, IR: internal rotation 485 
 486 
 487 
 488 
 489 
Table 5: Summary of the improvement in functional outcome in included studies  490 
Study Idiopathic Diabetic Secondary Statistically significant 
difference 
Nicholson 2003  
N = 68 
ASES 36.9 to 94.4 
(57.5) 
SST 4 to 11 (7) 
ASES 39.2 to 88 
(48.8) 
SST 2.5 to 9 (6.5) 
ASES 35.1 to 93.0 
(57.9) 
SST 3 to 10.4 (7.4) 
When diabetics compared against 
all other patients SST lower (9 vs. 
10; p = 0.009) 
Cinar et al 2010   
N = 28 
Constant 29.6 to 93.6 
UCLA 10.0 to 32.7 
Constant 30.4 to 82 
UCLA 10.1 to 29 
N/A 
N/A 
Improved Constant score in 
idiopathic group (P<0.05) 
Elhassan et al 
2010 
N = 115 
Constant 37 to 92 
SSV 26 to 77 
N/A 
N/A 
Constant 35 to 83.5 
SSV 30.6 to 71.1 
Post-surgical cases worse SSV 
than idiopathic cases (p=0.0001) 
Jerosch et al 
2013  
N = 173 
Constant 42 to 85 N/A Constant 41 to 78 Nil 
Mehta et al 2014  
N = 42 
Constant 38.4 to 88.6 Constant 36.6 to 
84.4 
N/A At 6 weeks and 6 months 
idiopathic group higher constant 
score (p<0.01) 
Cho et al 2016  
N = 37 
ASES 30 to 96.7 
UCLA 12.8 to 34.2 
ASES 28.1 to 95 
UCLA 11.7 to 34.4 
N/A 
N/A 
At 1 year idiopathic group had 
higher ASES than diabetic (88.8 
vs. 77.7; p=0.025) 
 491 
Table 6: Summary of the improvement in pain in included studies  492 
Study Idiopathic Diabetic Secondary Statistically significant 
difference 
Nicholson 2003   
N = 68 
VAS 7 to 0 (7) VAS 4.5 to 1 (3.5) VAS 6.4 to 0 (6.4) Nil 
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Cinar et al 2010  
N = 28 
Recurrent pain 
0% 
Recurrent pain 
26% 
N/A Nil 
Elhassan et al 
2010 
N = 115 
VAS 7.6 to 0.6 N/A VAS 7.4 to 1.2 Post-surgical cases worse 
pain relief than idiopathic 
cases (p=0.01) 
Mehta et al 2014   
N = 42 
 No pain 19 
Mild 2 
Moderate 0  
Severe 0 
No pain 14 
Mild 5 
Moderate 2  
Severe 0 
N/A 
N/A 
N/A 
N/A 
Nil  
Cho et al 2016  
N = 37 
VAS 7.4 to 1.4 (6) VAS 7 to 2.2 (4.8) N/A Nil 
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